Clinical TrialsSearch results
Number of results: 1470
Other
- A Phase 2/3 Study of SYR-322 as an Add-on to a Metformin
- Type 2 diabetes mellitus
- Takeda Pharmaceutical Company Limited
- 2009-04-01
Other
- A Phase 2/3 Study of SYR-322 as an Add-on to a Sulfonylurea
- Type 2 diabetes mellitus
- Takeda Pharmaceutical Company Limited
- 2009-04-01
Other
- A Phase 2/3 Study of SYR-322 as an Add-on to a Thiazolidine
- Type 2 diabetes mellitus
- Takeda Pharmaceutical Company Limited
- 2008-10-01
Other
- A Phase 2/3 Study of SYR-322 as an Add-on to an Alpha-Glucosidase Inhibitor
- Type 2 diabetes mellitus
- Takeda Pharmaceutical Company Limited
- 2008-10-01
Completed
- A Phase 2b Randomised, Double-Blind, Placebo-Controlled, Multi-Centre, Dose-Ranging Study of AZD5718 in Participants With Proteinuric Chronic Kidney Disease
- Chronic Kidney Disease
- Hibi Kazushige
- 2020-11-16
Other
- A Phase I Dose Intensification Study of three dimentional conformal thoracic radiotherapy with concurrent cisplatin and TS-1 for unresectable stage III non-small cell lung cancer
- non-small cell lung cancer
- Shizuoka Cancer Center, The Cancer Institute Hospital of JFCR
- 2008-12-02
Other
- A phase I study of cancer vaccine with NY-ESO-1 overlapping peptides in patients with advanced cancers expressing NY-ESO-1 antigen
- advanced esophageal cancer, stomach cancer, non-small cell lung cancer (NSCLC), malignant melanoma, bladder cancer.
- Department of Immunology Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences
- 2009-04-10
Recruiting
- A PHASE I STUDY OF ERY974 IN PATIENTS WITH HEPATOCELLULAR CARCINOMA
- LOCALLY ADVANCED OR METASTATIC HEPATOCELLULAR CARCINOMA
- Wataya Takafumi
- 2021-03-01
Recruiting
- A Phase I Study of NS-917 in Japanese Patients With Relapsed or Refractory Acute Myeloid Leukemia
- Acute Myeloid Leukemia
- Higashioka Masaya
- 2021-11-26
Other
- A phase I study of vaccination with NY-ESO-1f peptide mixed with Picibanil; OK-432 and Montanide; ISA-51 in patients with cancers expressing NY-ESO-1 antigen
- advanced esophageal cancer, stomach cancer, non-small cell lung cancer (NSCLC), malignant melanoma
- Department of Immunology Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences
- 2008-07-24